Tue, Sep 16, 2014, 12:15 PM EDT - U.S. Markets close in 3 hrs 45 mins

Recent

% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

  • frankposting frankposting Jul 11, 2013 7:59 PM Flag

    Timing of the Public Offer

    It is puzzled me why the company makes the public offer now.

    Do they urgently need money for survival right now. No, their cash position was at $200M as of 3/31/13.

    Seemingly, November is a much better timing. Why now? One issue is their previous $100M loan was collateralized by Vascepa's intellectual properties. If the company intend to take a buyout offer or a significant partnership, the suitor(s) should make sure the intellectual properties are totally owned by the company.

    Don't waste your time to argue with bashers about fish oil ..... If they don't do it, they are not bashers.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Seems like protecting the IP of the drug is a smart move. It lifts a "overhang" like the company had relayed may have been in their way from moving ahead (with BP).. Seems like anyone one who saw that as well is looking in the right direction..

      Just my opinion there...

    • I hate to point to the obvious but, given that there's no pressing need for more cash right now, the only good reason to do a secondary would be if you believed the pps was going lower. A pity they did not hols the same belief at $12.50!

    • It was definitely tied to the intellectual property situation. Amarin wanted to get this off the table.

      Sentiment: Strong Buy

    • its in the 10-k. to launch marine.

    • The answer is simple: to make the most money for themselves and their cronies. The very same reason Amarin executives awarded themselves thousands of free shares today. Wake up!

    • Frank
      I think it's the cash burn rate ...something like $62 m to launch the drug so far and expected debt pyts going forward on the loan you mentioned etc thru 2015 .
      Amarin is finding it's expensive for a small biotech to launch a new drug.
      My view is that they have modeled out a worst case scenario of cash flo .... to ensure survival until the Reduce it trial ends ...at which time we will either have expensive fish oil OR a blockbuster drug
      AK

      • 1 Reply to akanz2
      • AK,

        it is too important to figure out the dynamics behind the offering. JZ said that, before the offering, the cash position is enough to go thro 2Q14 (now said that, with the offering, it is enough to go thro entire 2014). Such that, debt is not enough to address the timing, because November is obviously a much better time (in consideration of money alone) than September, for the offering. The company does the offering at the low price and 4 months before the obviously better timing, the dynamics behind the offering should be stronger than that $120M alone!

    • Its probably just for negotiation purposes on ANCHOR partnership or BuyOut. If they didn't have the cash, BP can say u have no money so u need us....we will pay u $X amount and take it or leave it or go it alone by yourself

    • I agree with you Frank, why now? However, I don't get your point about intellectual property, Amarin's patents are all their own. Can you explain?

      Thanks.

 
AMRN
1.38-0.04(-2.82%)12:15 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.